As a member of the AMPK-related kinase family, MELK is overexpressed in various malignancies including breast cancer, hepatocellular carcinoma, and glioma, where it drives oncogenesis by regulating cell cycle progression, cancer stemness, and therapy resistance (43, 44). Here, MELK is linked to hepatocellular carcinoma.